ArticleMolecular biology reports2026
Loss of SEL1L or Hrd1 increases intrinsic LOX levels in HEK293 cells independently of proteasomal degradation.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWe previously established HEK293 cells deficient in SEL1L, a key component of endoplasmic reticulum-associated protein degradation (ERAD), and attempted to identify factors affected by ERAD dysfunction through comprehensive MS analysis. Among the factors increased by SEL1L-deficiency, lysyl oxidase (LOX) which plays a role in extracellular matrix cross-linking was involved. METHODS AND
resultsTo elucidate the regulatory mechanisms of LOX mRNA and protein, we applied several ERAD-deficient cells and drug treatments. In SEL1L-deficient cells, LOX mRNA expression levels were observed to increase approximately twofold, and the increase in high molecular weight preproLOX protein was more remarkable in each SEL1L deletion. SEL1L-deficiency also slightly increased the amount of secreted LOX protein cleaved by proteases. Increased proproLOX was also observed in cells lacking Hrd1 that associates with SEL1L. Interestingly, LOX protein was hardly increased in cells deficient for EDEM2 and TXNDC11, which are involved in mannose trimming of N-glycosylated proteins. Since ERAD failure may induce sustained ER stress, we examined the effects of three ER stress inducers on LOX expression. Changes in LOX mRNA following 6-h treatment with each reagent was negligible compared to the major ER stress-inducible mRNA. In contrast, long-term treatment with thapsigargin and tunicamycin increased intracellular LOX protein, but significantly decreased secreted LOX protein. Finally, we examined the effects of proteasome and lysosome inhibitors on LOX expression and, unexpectedly, each reagent hardly increased LOX mRNA or protein levels.
conclusionsThese results suggest that expression of intrinsic LOX protein is regulated by SEL1L and Hrd1 in a ubiquitin-proteasome-independent manner.
Indexed as
Identifiers
41518417What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.